Skip to content
PICO Portalanswers from OpenAlex

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer

PaperCitations, authors & open-access status

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer have?

PICO Portalcitation count

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer has 119 citations in the OpenAlex counts PICO Portal stores.

When was EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer published?

PICO Portalyear

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer has 2019 year in the PICO Portal index.

What is the open-access status of EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer?

PICO Portaloa status

EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer has gold oa status in the PICO Portal index.

What is the DOI of EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer?

PICO Portaldoi

The DOI for EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer is on the source record.

What is the PMID of EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer?

PICO Portalpmid

The PMID for EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer is on the source record.

What is the OpenAlex record for EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer?

PICO Portalopenalex

The OpenAlex for EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial